Geron Corporation (GERN)
Quick facts
| Ticker | GERN (NASDAQ) |
|---|
Marketed products
- Rytelo · Oncology
Rytelo works by inhibiting the activity of telomerase, an enzyme that helps cancer cells grow and divide.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: